128 related articles for article (PubMed ID: 28703900)
1. Rapid genetic counseling and testing in newly diagnosed breast cancer: Patients' and health professionals' attitudes, experiences, and evaluation of effects on treatment decision making.
Wevers MR; Aaronson NK; Bleiker EMA; Hahn DEE; Brouwer T; van Dalen T; Theunissen EB; van Ooijen B; de Roos MA; Borgstein PJ; Vrouenraets BC; Vriens E; Bouma WH; Rijna H; Vente JP; Kuenen MA; van der Sanden-Melis J; Witkamp AJ; Rutgers EJT; Verhoef S; Ausems MGEM
J Surg Oncol; 2017 Dec; 116(8):1029-1039. PubMed ID: 28703900
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients.
Schwartz MD; Peshkin BN; Isaacs C; Willey S; Valdimarsdottir HB; Nusbaum R; Hooker G; O'Neill S; Jandorf L; Kelly SP; Heinzmann J; Zidell A; Khoury K
Breast Cancer Res Treat; 2018 Aug; 170(3):517-524. PubMed ID: 29611029
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: design of a multicenter randomized clinical trial.
Wevers MR; Ausems MG; Verhoef S; Bleiker EM; Hahn DE; Hogervorst FB; van der Luijt RB; Valdimarsdottir HB; van Hillegersberg R; Rutgers EJ; Aaronson NK
BMC Cancer; 2011 Jan; 11():6. PubMed ID: 21219598
[TBL] [Abstract][Full Text] [Related]
4. Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial.
Wevers MR; Aaronson NK; Verhoef S; Bleiker EM; Hahn DE; Kuenen MA; van der Sanden-Melis J; Brouwer T; Hogervorst FB; van der Luijt RB; Valdimarsdottir HB; van Dalen T; Theunissen EB; van Ooijen B; de Roos MA; Borgstein PJ; Vrouenraets BC; Vriens E; Bouma WH; Rijna H; Vente JP; Witkamp AJ; Rutgers EJ; Ausems MG
Br J Cancer; 2014 Feb; 110(4):1081-7. PubMed ID: 24423928
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial impact of proactive rapid genetic counseling following breast cancer diagnosis.
Kritzik R; Usoro E; Peshkin BN; Isaacs C; Valdimarsdottir HB; Willey S; O'Neill S; DeMarco T; Nusbaum R; Jandorf L; Kelleher S; Schwartz MD
Psychooncology; 2022 May; 31(5):788-797. PubMed ID: 34921700
[TBL] [Abstract][Full Text] [Related]
6. Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trial.
Wevers MR; Ausems MG; Verhoef S; Bleiker EM; Hahn DE; Brouwer T; Hogervorst FB; van der Luijt RB; van Dalen T; Theunissen EB; van Ooijen B; de Roos MA; Borgstein PJ; Vrouenraets BC; Vriens E; Bouma WH; Rijna H; Vente JP; Kieffer JM; Valdimarsdottir HB; Rutgers EJ; Witkamp AJ; Aaronson NK
Genet Med; 2016 Feb; 18(2):137-44. PubMed ID: 25905441
[TBL] [Abstract][Full Text] [Related]
7. A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian women.
Cortesi L; Razzaboni E; Toss A; De Matteis E; Marchi I; Medici V; Tazzioli G; Andreotti A; De Santis G; Pignatti M; Federico M
Ann Oncol; 2014 Jan; 25(1):57-63. PubMed ID: 24276029
[TBL] [Abstract][Full Text] [Related]
8. Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study.
Wevers MR; Schmidt MK; Engelhardt EG; Verhoef S; Hooning MJ; Kriege M; Seynaeve C; Collée M; van Asperen CJ; Tollenaar RA; Koppert LB; Witkamp AJ; Rutgers EJ; Aaronson NK; Rookus MA; Ausems MG
Fam Cancer; 2015 Sep; 14(3):355-63. PubMed ID: 25700605
[TBL] [Abstract][Full Text] [Related]
9. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
[TBL] [Abstract][Full Text] [Related]
10. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
11. How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
Watts KJ; Meiser B; Mitchell G; Kirk J; Saunders C; Peate M; Duffy J; Kelly PJ; Gleeson M; Barlow-Stewart K; Rahman B; Friedlander M; Tucker K;
BMC Cancer; 2012 Jul; 12():320. PubMed ID: 22838957
[TBL] [Abstract][Full Text] [Related]
12. Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.
Ardern-Jones A; Kenen R; Eeles R
Eur J Cancer Care (Engl); 2005 Jul; 14(3):272-81. PubMed ID: 15952973
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact.
Wevers MR; Hahn DE; Verhoef S; Bolhaar MD; Ausems MG; Aaronson NK; Bleiker EM
Patient Educ Couns; 2012 Oct; 89(1):89-95. PubMed ID: 22543000
[TBL] [Abstract][Full Text] [Related]
14. Knowledge regarding and patterns of genetic testing in patients newly diagnosed with breast cancer participating in the iCanDecide trial.
Gornick MC; Kurian AW; An LC; Fagerlin A; Jagsi R; Katz SJ; Hawley ST
Cancer; 2018 Oct; 124(20):4000-4009. PubMed ID: 30289174
[TBL] [Abstract][Full Text] [Related]
15. Moving into the mainstream: healthcare professionals' views of implementing treatment focussed genetic testing in breast cancer care.
Hallowell N; Wright S; Stirling D; Gourley C; Young O; Porteous M
Fam Cancer; 2019 Jul; 18(3):293-301. PubMed ID: 30689103
[TBL] [Abstract][Full Text] [Related]
16. Health professionals' evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer.
Douma KF; Meiser B; Kirk J; Mitchell G; Saunders C; Rahman B; Sousa MS; Barlow-Stewart K; Gleeson M; Tucker K
Fam Cancer; 2015 Jun; 14(2):265-72. PubMed ID: 25391616
[TBL] [Abstract][Full Text] [Related]
17. Active approach for breast cancer genetic counseling during radiotherapy: long-term psychosocial and medical impact.
Baars JE; Bleiker EM; van Riel E; Rodenhuis CC; Velthuizen ME; Schlich KJ; Ausems MG
Clin Genet; 2014 Jun; 85(6):524-31. PubMed ID: 24372530
[TBL] [Abstract][Full Text] [Related]
18. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.
Vadaparampil ST; Quinn GP; Miree CA; Brzosowicz J; Carter B; Laronga C
Ann Surg Oncol; 2009 Jul; 16(7):1973-81. PubMed ID: 19408048
[TBL] [Abstract][Full Text] [Related]
19. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
[TBL] [Abstract][Full Text] [Related]
20. BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing.
Van Riel E; Wárlám-Rodenhuis CC; Verhoef S; Rutgers EJ; Ausems MG
Eur J Cancer Care (Engl); 2010 May; 19(3):369-76. PubMed ID: 19659662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
